CompletedNot Applicable

Prevention of Skin Problems With Diabetes Devices in Pediatric Patients

Denmark236 participantsStarted 2020-03-10

Plain-language summary

A Cluster-controlled Intervention Trial regarding Prevention of Dermatological Complications towards use of Continuous glucose monitoring and insulin pumps in pediatric patients with Type 1 Diabetes. The patients will be followed prospectively with visits every 3rd month for the first year of initiation of device. Besides a standardized treatment plan if dermatological complications evolve, will be used.

Who can participate

Age range2 Years – 20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with Type 1 Diabetes * Initiating either Insulin pump, Flash glucose monitorer or continuous glucose monitor Exclusion Criteria: \*Language difficulties regarding Danish

What they're measuring

Incidence of dermatological complications

Timeframe: Up to 12 months after inclusion

Trial details

NCT IDNCT04258904

SponsorCopenhagen University Hospital at Herlev

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-09-20

View on ClinicalTrials.gov More Type 1 Diabetes trials